Gossamer Bio Inc
(FRA:4GB)
€
0.477
-0.0156 (-3.17%)
Market Cap: 114.25 Mil
Enterprise Value: 81.34 Mil
PE Ratio: 0
PB Ratio: 4.60
GF Score: 35/100 Gossamer Bio Inc (FRA:4GB) Transcripts
- Gossamer Bio Inc To Discuss Latest Seralutinib Open-Label Extension Data TranscriptDec 18, 2023
- Gossamer Bio Inc To Discuss Seralutinib Program Update Call TranscriptJul 25, 2023
- Gossamer Bio Inc at Goldman Sachs Healthcare Conference TranscriptJun 13, 2023
- Gossamer Bio Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Gossamer Bio Inc To Discuss TORREY Topline Results Call TranscriptDec 06, 2022
- Gossamer Bio Inc at UBS Global Healthcare Conference TranscriptMay 25, 2022
- Gossamer Bio Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Gossamer Bio Inc To Discuss Phase 2 SHIFT-UC Topline Clinical Trial Results Call TranscriptApr 25, 2022
- Gossamer Bio Inc at Barclays Global Healthcare Conference TranscriptMar 16, 2022
- Q4 2021 Gossamer Bio Inc Earnings Call TranscriptMar 03, 2022€8.25 (+2.48%)Earnings
- Q3 2021 Gossamer Bio Inc Earnings Call TranscriptNov 08, 2021€11.3Earnings
- Gossamer Bio Inc at Jefferies Next Generation IBD Therapeutics Summit (Virtual) TranscriptOct 19, 2021
- Gossamer Bio Inc Investor Day TranscriptOct 11, 2021
- Q2 2021 Gossamer Bio Inc Earnings Call TranscriptAug 09, 2021€6.9Earnings
- Gossamer Bio Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 11, 2021
- Gossamer Bio Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 10, 2021
- Q4 2020 Gossamer Bio Inc Earnings Call TranscriptFeb 25, 2021€8.35 (+2.45%)Earnings
- Gossamer Bio, Inc. - Special Call TranscriptFeb 18, 2021
- Gossamer Bio, Inc. - Special Call TranscriptDec 15, 2020
- Q3 2020 Gossamer Bio Inc Earnings Call TranscriptNov 10, 2020€7.7 (+6.21%)Earnings
- Gossamer Bio Inc to Discuss Topline Results for Phase 2 Trials of Oral GB001 in Asthma and Chronic Rhinosinusitis Call TranscriptOct 13, 2020
- Gossamer Bio Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 11, 2020
- Gossamer Bio Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 14, 2020
- Q1 2020 Gossamer Bio Inc Earnings Call TranscriptMay 12, 2020€11.1Earnings
- Q3 2019 Gossamer Bio Inc Earnings Call TranscriptNov 12, 2019€20.4Earnings
- Q2 2019 Gossamer Bio Inc Earnings Call TranscriptAug 08, 2019€17.5 (+6.06%)Earnings
- Gossamer Bio Inc at Bank of America Merrill Lynch Global Metals, Mining & Steel Conference TranscriptMay 14, 2019
- Q1 2019 Gossamer Bio Inc Earnings Call TranscriptMay 14, 2019€17.66 (+4.19%)Earnings
- 1